Navigating CD Ladders Amidst Anticipated Interest Rate Declines
Finance

Navigating CD Ladders Amidst Anticipated Interest Rate Declines

authorBy Lisa Jing
DateJul 09, 2026
Read time3 min

In the dynamic financial world, Certificate of Deposit (CD) laddering has emerged as a clever strategy for many savers, especially with the high annual percentage yields observed in 2023 and 2024. As the Federal Reserve contemplates reducing interest rates in 2025, the prudence of this strategy comes into focus. While future CD rates might not reach the peaks of previous years, initiating a CD ladder now could be a strategic move to secure higher returns on future maturing CDs.

CD Laddering: A Strategic Investment Approach in Anticipation of Rate Adjustments

A CD ladder involves several certificates of deposit, each equally funded but with varying maturity dates. This method allows investors to capitalize on elevated annual percentage yields while also maintaining liquidity, as different CDs mature periodically. Upon maturity, investors have the flexibility to either reinvest the funds or withdraw them without incurring penalties. For instance, an investor could simultaneously open one-year, two-year, and three-year CDs, each with an equal deposit. When the one-year CD matures, the funds can be reinvested into a new three-year CD. This cycle continues with subsequent maturities, ensuring a continuous stream of maturing investments each year.

Unlike conventional savings or money market accounts, Certificates of Deposit generally offer superior annual percentage yields. These rates are fixed for the duration of each CD's term, guaranteeing a specific return. This contrasts sharply with the variable rates of other account types. Historically, top-performing CDs have provided APYs significantly higher—sometimes two to three times—than the national averages reported by the Federal Deposit Insurance Corporation (FDIC).

Looking ahead to 2025, the Federal Reserve's stance on interest rates is crucial. Following a period of aggressive rate hikes to combat inflation, the Fed initiated cautious reductions between September and December 2024. Despite pausing rate adjustments in January 2025, further, albeit modest, cuts are anticipated for the year. December 2024 projections from Fed committee members indicated an expected 0.75% reduction over the year. This forecast suggests that CD interest rates could remain relatively attractive, making the current period an opportune time to establish a CD ladder before any further rate cuts take effect.

However, a potential decline in interest rates could affect CD ladders. If rates fall significantly, banks and lenders might offer lower returns on new CDs. Investors who delay starting their CD ladders could find themselves with reduced yields or might need to opt for longer-term CDs to achieve desirable returns. This scenario highlights a key disadvantage of CDs: the unpredictability of future interest rates. Conversely, if interest rates unexpectedly climb, an investor might reinvest maturing short-term CDs at more favorable rates. This inherent variability underscores the importance of strategic planning in CD laddering.

The current financial climate presents a compelling argument for establishing a CD ladder. By acting now, investors can lock in relatively high annual percentage yields and benefit from the strategy's inherent liquidity, even as interest rates are expected to trend downwards. This approach allows for a balanced portfolio that combines stability with growth potential, adapting to the evolving economic landscape.

More Articles
Finance
Asia's Monetary Policy Stance Amidst Global Oil Price Fluctuations
Despite a recent dip in global oil prices, central banks in Asia are unlikely to alter their current monetary tightening strategies. The persistent threat of inflation, particularly in food and core consumer goods, coupled with exchange rate vulnerabilities and limited capital inflows, means these economies must remain vigilant. A sustained period of inflation moderation and improved external balances are prerequisites for any potential shift towards looser monetary policies in the region.
By Nouriel RoubiniJul 09, 2026
Finance
Nomura Holdings: Promising Outlook for Core Business Segments
This analysis maintains a 'Buy' rating for Nomura Holdings, Inc., highlighting the positive prospects for its Wholesale and Wealth Management divisions. The Wholesale segment is poised for enhanced Return on Equity through strategic internal adjustments and a supportive M&A environment. Concurrently, the Wealth Management unit is expanding its offerings and client base to secure a greater proportion of recurring revenue in the future, signaling a robust growth trajectory for the company's key operations.
By Robert KiyosakiJul 09, 2026
Finance
Clorox: Balancing Dividend Appeal with Valuation Concerns
Clorox continues to be a defensive investment for dividend seekers, despite recent stock declines. The company's premium valuation remains a key concern, potentially leading to price stabilization rather than significant gains. However, a market shift towards staples or accelerated growth could improve its outlook. This analysis maintains a cautious perspective, advising observation from the sidelines.
By Strive MasiyiwaJul 09, 2026
Finance
Navigating Global Uncertainties: Geopolitical Tensions and Market Responses
Amidst escalating geopolitical tensions involving Iran, global markets are grappling with rising oil prices and surging Treasury yields. Despite robust domestic economic fundamentals, these external pressures are creating significant headwinds. A recent, hastily brokered ceasefire with Iran, while averting immediate conflict escalation, ensures continued market volatility and elevated energy costs. The Trump administration faces increasing pressure to de-escalate as rising interest rates threaten economic stability, especially with upcoming elections. Experts anticipate a swift reduction in military activities and a stabilization of yields, with the Federal Reserve likely to maintain steady interest rates to mitigate geopolitical shocks.
By Strive MasiyiwaJul 09, 2026
Finance
Exelixis' Zanzalintinib: A Detailed Analysis of Its Clinical Trials and Market Prospects
This article delves into Exelixis' zanzalintinib, analyzing the mixed results of its STELLAR-303 trial for colorectal cancer and the anticipated success of STELLAR-304 in renal cell carcinoma. It explores the drug's commercial viability, regulatory hurdles, and potential market uptake, alongside the company's share repurchase program aimed at stabilizing investor confidence.
By Morgan HouselJul 09, 2026